Thirty Respiratory Limited

Research activity is centred on non-cystic fibrosis bronchiectasis, with attention to patients carrying Pseudomonas aeruginosa and other potentially pathogenic micro-organisms in the airways. The clinical focus reflects interest in persistent respiratory infection and chronic airway disease.

• Chronic suppurative lung disease
• Airway colonisation
• Respiratory infection

Thirty Respiratory Limited is engaged in the therapeutic area of bronchiectasis management, with emphasis on infection-related respiratory morbidity.